Geralyn Lambert-Messerlian

No ORCID on file · 3 papers in corpus
other 2015
Assessing the risk of ovarian malignancy algorithm for the conservative management of women with a pelvic mass
Gynecologic Oncology ·doi:10.1016/j.ygyno.2015.09.010

OBJECTIVE: To evaluate the use of as an aid in the identification of women who can safely undergo conservative, non-surgical management. METHODS: All patients referred to the Program in Women's Oncology for surgery with a pelvic mass are e…

observational 2012
Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2011.12.029

OBJECTIVE: The human epididymis protein 4 (HE4) is a novel biomarker for ovarian cancer. This study measured the HE4 and CA125 levels in women with benign gynecological disorders. STUDY DESIGN: Sera were obtained from women prior to surger…

meta-analysis 2012
Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2011.12.028

OBJECTIVE: The purpose of this study was to establish normal ranges for human epididymis protein 4 (HE4) serum levels in healthy women. STUDY DESIGN: HE4 levels were measured in healthy women and analyzed by age, menopausal status, and pre…